Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
Human Papilloma Virus
About this trial
This is an interventional prevention trial for Human Papilloma Virus focused on measuring Health Messaging, Health Education, Human Papilloma Virus, HPV Vaccination
Eligibility Criteria
Inclusion Criteria:
- Women who are patients at the clinic
- Age 18+
- Have a working mobile phone with SMS capability
Exclusion Criteria:
- Male
- <18 years of age
- Do not have a working mobile phone with SMS capability
Sites / Locations
- University of California Los Angeles
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Health Messaging via SMS
CDC Pamphlets
Clinics randomized to this arm will receive the health messaging via SMS intervention. Flyers and information cards will be made available in all exam rooms and the waiting room, which contain information about the health messaging program. Patients must voluntarily elect to enroll in the program using their mobile device. Patients who enroll will receive a variety of health messages on topics including HPV Vaccine, Cervical Cancer screening, Birth Control options, Menstrual Problems, diet and exercise. Text messages are sent out using a third party interface, Twilio, at a frequency of 2 times each week for a duration of 1 year. These are one-way messages which only allow for texts to be sent to the participant.
The clinic randomized to this control arm will receive standard Center for Disease Control health pamphlets about the HPV Vaccine. Flyers are posted in the clinic waiting room and exam room.